Chinese biotech Minghui raises $131M to advance its PD-1xVEGF bispecific
Article Title: Chinese biotech Minghui raises $131M to advance its PD-1xVEGF bispecific Publication Date: August 07, 2025 In a move that brings the growing power of Chinese biotech into focus once again, Minghui Pharmaceutical, headquartered in Shanghai, has secured an…